170 related articles for article (PubMed ID: 8848557)
21. Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on enzymes in rat liver and on carcinogen-induced liver altered foci in comparison to the promoter phenobarbital.
Maruyama H; Tanaka T; Williams GM
Toxicol Pathol; 1990; 18(2):257-67. PubMed ID: 1975953
[TBL] [Abstract][Full Text] [Related]
22. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats.
Tatematsu M; Mera Y; Ito N; Satoh K; Sato K
Carcinogenesis; 1985 Nov; 6(11):1621-6. PubMed ID: 2865013
[TBL] [Abstract][Full Text] [Related]
23. Quantitative relationship between initiation of hepatocarcinogenesis and induction of altered cell islands.
Kaufmann WK; MacKenzie SA; Rahija RJ; Kaufman DG
J Cell Biochem; 1986; 30(1):1-9. PubMed ID: 3082898
[TBL] [Abstract][Full Text] [Related]
24. Clonal isolation of populations of gamma-glutamyl transpeptidase-positive and -negative cells from rat liver epithelial cells chemically transformed in vitro.
Tsao MS; Grisham JW; Chou BB; Smith JD
Cancer Res; 1985 Oct; 45(10):5134-8. PubMed ID: 2862991
[TBL] [Abstract][Full Text] [Related]
25. The slow induction of resistant hepatocytes during initiation of hepatocarcinogenesis by the nongenotoxic carcinogen clofibrate.
Nagai MK; Farber E
Exp Mol Pathol; 1999 Dec; 67(3):144-9. PubMed ID: 10600397
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of multiple phenotype enzyme-altered foci in rat hepatocarcinogenesis experiments: the multipath/multistage model.
Sherman CD; Portier CJ
Carcinogenesis; 1995 Oct; 16(10):2499-506. PubMed ID: 7586158
[TBL] [Abstract][Full Text] [Related]
27. Effect of the antihistamine, methapyrilene, as an initiator of hepatocarcinogenesis in female rats.
Glauert HP; Pitot HC
Cancer Lett; 1989 Aug; 46(3):189-94. PubMed ID: 2569926
[TBL] [Abstract][Full Text] [Related]
28. [Laboratory study on the relationship between drinking water and hepatoma--quantitative evaluation using hepatic gamma-GT method].
Zhou TL; Yu SZ
Zhonghua Yu Fang Yi Xue Za Zhi; 1990 Jul; 24(4):203-5. PubMed ID: 1976494
[TBL] [Abstract][Full Text] [Related]
29. Promoting potential of a Jamaica quassia extract in a rat medium-term hepatocarcinogenesis bioassay.
Woo GH; Shibutani M; Inoue K; Fujimoto H; Takahashi M; Lee KY; Hirose M
Food Chem Toxicol; 2007 Jul; 45(7):1160-4. PubMed ID: 17306917
[TBL] [Abstract][Full Text] [Related]
30. Lack of acetylaminofluorene--DNA adduct formation in enzyme-altered foci of rat liver.
Huitfeldt HS; Hunt JM; Pitot HC; Poirier MC
Carcinogenesis; 1988 Apr; 9(4):647-52. PubMed ID: 2895693
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: a combined morphological and enzyme histochemical approach.
Moore MA; Hacker HJ; Kunz HW; Bannasch P
Carcinogenesis; 1983; 4(4):473-9. PubMed ID: 6132686
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
33. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis.
Hirota N; Williams GM
Am J Pathol; 1979 May; 95(2):317-28. PubMed ID: 222150
[TBL] [Abstract][Full Text] [Related]
34. Effects of the hepatocarcinogenic peroxisome-proliferating hypolipidemic agents clofibrate and nafenopin on the rat liver cell membrane enzymes gamma-glutamyltranspeptidase and alkaline phosphatase and on the early stages of liver carcinogenesis.
Numoto S; Furukawa K; Furuya K; Williams GM
Carcinogenesis; 1984 Dec; 5(12):1603-11. PubMed ID: 6149819
[TBL] [Abstract][Full Text] [Related]
35. Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver.
Campbell HA; Xu YD; Hanigan MH; Pitot HC
J Natl Cancer Inst; 1986 Apr; 76(4):751-67. PubMed ID: 2870209
[TBL] [Abstract][Full Text] [Related]
36. An enzyme histochemical analysis of the different steps in thioacetamide induced liver carcinogenesis in rats.
Praet MM; Roels HJ
Acta Histochem Suppl; 1989; 37():161-7. PubMed ID: 2570441
[No Abstract] [Full Text] [Related]
37. The initiation-promotion-progression model of rat hepatocarcinogenesis.
Dragan YP; Sargent L; Xu YD; Xu YH; Pitot HC
Proc Soc Exp Biol Med; 1993 Jan; 202(1):16-24. PubMed ID: 8093813
[TBL] [Abstract][Full Text] [Related]
38. Separation of two populations of cells with gamma-glutamyl transpeptidase from carcinogen-treated rat liver.
Jacobs JM; Pretlow TP; Fausto N; Pitts AM; Pretlow TG
J Natl Cancer Inst; 1981 May; 66(5):967-73. PubMed ID: 6112283
[TBL] [Abstract][Full Text] [Related]
39. Promotion of hepatocarcinogenesis in vivo and in vitro.
Kitagawa T; Kayano T; Mikami K; Watanabe R; Sugano H
Princess Takamatsu Symp; 1983; 14():337-48. PubMed ID: 6151563
[TBL] [Abstract][Full Text] [Related]
40. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
